Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
20.15    0.79 (4.08%)
Bid:
20.15
Ask:
20.25
Spread: 0.10 (0.496%)
Market Cap: £375.01m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Form 8 (OPD) EnQuest PLC

20 Mar 2025 09:00

RNS Number : 4785B
EnQuest PLC
20 March 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

EnQuest Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

EnQuest plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

19 March 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

0.05 pence Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Name

Number of Ordinary Shares held

Percentage of total issued share capital

Beneficial Owner/ Controller

Amjad Bseisu

234,732,857

12.61

Amid Bseisu

Gareth Penny

137,047

0.00

Gareth Penny

Farina Khan

211,235

0.01

Farina Khan

Total:

235,081,139

12.63

a) Holdings of directors of EnQuest plc

 

 

Notes:

1. 201,881,058 shares are held by Double A Limited, a company beneficially owned by the extended family of Amjad Bseisu. 32,674,840 shares are also held by The Amjad and Suha Bseisu Foundation and 176,959 shares are held directly by Amjad Bseisu.

 

2. 62,500 shares are held by Gareth Penny, and 74,547 shares are held by his wife, Kate Penny

 

b) Options and awards held by directors of EnQuest plc

Name

Number of EnQuest shares awarded

Date of grant

Date of vesting

Date of expiry

Exercise price

Executive Director Deferred Bonus Share Award

Amjad Bseisu

72,475

10 September 2020

9 September 2022

9 September 2030

£0.1209

Name

Number of EnQuest shares awarded

Date of grant

Date of vesting

Date of expiry

Exercise price

PSP Award

Amjad Bseisu

5,303,3511

10 September 2020

10 September 2023

9 September 2030

£0.1664

1,488,4092

27 April 2021

27 April 2024

26 April 2031

£0.1617

3,343,689

25 April 2022

25 April 2025

24 April 2032

£0.358239

8,102,723

10 July 2023

25 April 2026

25 April 2033

£0.152267

6,054,872

25 April 2024

25 April 2027

25 April 2034

£0.1566

Jonathan Copus

4,718,390

25 April 2024

25 April 2027

25 April 2034

£0.1566

 

Notes:

1. The original award was for 7,090,042 shares however 1,786,691 shares were cancelled on 6 March 2023.

2. The original award was for 7,442,048 shares however 5,953,639 shares were cancelled on 1 March 2024.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

20 March 2025

Contact name:

Kate Christ

Telephone number:

020 7925 4900

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEVBLBLEXLBBBQ
Date   Source Headline
22nd May 20265:10 pmRNSResults Of The Annual General Meeting
22nd May 20267:00 amRNSAGM Statement
13th May 20269:19 amRNSDirector Update
30th Apr 20263:30 pmRNSSUCCESSFUL SETTLEMENT OF NEW BOND ISSUE
29th Apr 20263:45 pmRNSNotice of Redemption and Cancellation of Listing
23rd Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
22nd Apr 20267:00 amRNSPricing of new bond issue
9th Apr 202610:07 amRNSEnQuest response to NSTA sanctions
2nd Apr 20268:00 amRNSPSC Signing in Peninsular Malaysia
25th Mar 20264:15 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSResults for the year ended 31 December 2025
13th Mar 202610:00 amRNSHolding(s) in Company
13th Mar 202610:00 amRNSHolding(s) in Company
2nd Mar 20264:26 pmRNSHolding(s) in Company
24th Feb 20264:44 pmRNSTotal Voting Rights
23rd Feb 20267:00 amRNSFebruary Operations Update
11th Feb 20267:00 amRNSEnQuest awarded PSC interest in Malaysia
9th Feb 20267:00 amRNSEnQuest awarded PSC extension
17th Dec 20257:00 amRNSDecember Operations Update
16th Dec 20251:00 pmRNSHolding(s) in Company
28th Nov 20254:00 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNS-REnQuest wins 'Excellence in Decommissioning' award
21st Nov 20251:00 pmRNSHolding(s) in Company
10th Nov 20257:00 amRNSNew senior secured debt facilities
31st Oct 202511:52 amRNSTotal Voting Rights
13th Oct 202512:15 pmRNSDirector/PDMR Shareholding
7th Oct 202511:59 amRNSDirector/PDMR Shareholding
24th Sep 20257:00 amRNSHalf-year Results
26th Aug 20257:00 amRNSEnQuest PLC - Gaea and Gaea II PSC execution
14th Aug 20257:00 amRNSCompletion of Heather Topsides Heavy Lift
16th Jul 202510:00 amRNSPSC award in Brunei Darussalam
10th Jul 20257:00 amRNSCompletion of Vietnam acquisition
1st Jul 20252:00 pmRNSHolding(s) in Company
19th Jun 202512:00 pmRNSReport on Payments to Govts
10th Jun 20257:00 amRNS-REnQuest PLC - Malaysia Operator of the Year award
27th May 20256:08 pmRNSAGM Reesults
27th May 20257:00 amRNSOperations Update
9th May 202510:00 amRNSHolding(s) in Company
9th May 202510:00 amRNSHolding(s) in Company
6th May 202512:00 pmRNSForm 8.5 (EPT/RI) - EnQuest Plc
6th May 202511:20 amRNSForm 8.5 (EPT/NON-RI)-EnQuest plc
6th May 202510:46 amRNSForm 8.5 (EPT/RI)-EnQuest plc
6th May 20257:00 amRNSForm 8.5 (EPT/RI) - Enquest PLC
6th May 20257:00 amRNS20250502_ENQUEST PLC_8.5 EPT RI_UK_MLI
2nd May 20253:15 pmRNSResponse to Statement by EnQuest plc
2nd May 20252:57 pmRNSRule 2.8 Announcement
2nd May 202512:00 pmRNSForm 8.5 (EPT/RI) Enquest Plc
2nd May 202511:21 amRNS20250501_ENQUEST PLC_8.5 EPT RI_UK_MLI
2nd May 202511:17 amRNSForm 8.5 (EPT/RI) - Enquest PLC
2nd May 202510:53 amRNSForm 8.5 (EPT/RI)-EnQuest plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.